Thanks Richo.
That makes sense. It has to open markets and awareness when more eyes are looking at the company name.
I was looking at the immediate short-term effect, which might only be small or none. Medium-term volitility gives good trading opportunities. Long-term - yes, that should definitely be good.
Also with more US investors, there would be more pressure to get the govt and medical authorities to accept the products.
Overall, it must be good for the company. The only possible negative seems to be volitility.
reasons why the nasdaq listing won't happen, page-7
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.5¢ | $469.8K | 1.579M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 297652 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 7500 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |